Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Renaissance Washington DC Downtown Hotel

Jan 26, 2015 8:30 AM - Jan 28, 2015 4:00 PM

999 Ninth Street NW, Washington, DC 20001

Pharmacovigilance and Risk Management Strategies 2015

Session 6 - Regional Requirements with Global Impact: The Drivers for Change

Session Chair(s)

Justina  Molzon, JD, MS

Justina Molzon, JD, MS

Consumer Services

Consumer Services, United States

Michael  Richardson, MD, FFPM, FRCP

Michael Richardson, MD, FFPM, FRCP

Senior Vice President, WorldWide Patient Safety

Bristol-Myers Squibb, United Kingdom

Speaker(s)

Robert  Ball, MD, MPH, MSc

FDA Perspective on International Regulatory Collaborations in Pharmacovigilance

Robert Ball, MD, MPH, MSc

FDA, United States

Deputy Director, Office of Surveillance and Epidemiology, CDER

Noha  Kassem, PhD

Pharmacovigilance System Master File

Noha Kassem, PhD

Eli Lilly & Company Ltd., United Kingdom

Senior Director of Quality in Global Patient Safety

Justina  Molzon, JD, MS

A View of APEC

Justina Molzon, JD, MS

Consumer Services, United States

Consumer Services

Eileen  Leonard, PharmD

Global Database and Accommodating Differing Reporting Requirements and Safety Analysis

Eileen Leonard, PharmD

Bristol-Myers Squibb Company, United States

Vice President, Worldwide Patient Safety

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.